Guriqbal S. Basi - Net Worth and Insider Trading

Guriqbal S. Basi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Guriqbal S. Basi owns 1 companies in total, including Sarepta Therapeutics Inc (SRPT) .

Click here to see the complete history of Guriqbal S. Basi’s form 4 insider trades.

Insider Ownership Summary of Guriqbal S. Basi

Ticker	Comapny	Transaction Date	Type of Owner
SRPT	Sarepta Therapeutics Inc	2017-09-25	SVP & Chief Scientific Officer

Guriqbal S. Basi Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Guriqbal S. Basi Ownership Network

Ownership Network List of Guriqbal S. Basi

No Data

Ownership Network Relation of Guriqbal S. Basi

Guriqbal S. Basi Owned Company Details

What does Sarepta Therapeutics Inc do?

Who are the key executives at Sarepta Therapeutics Inc?

Guriqbal S. Basi is the SVP & Chief Scientific Officer of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .

Sarepta Therapeutics Inc (SRPT) Insider Trades Summary

Over the past 18 months, Guriqbal S. Basi made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net sale of 40,957 shares made by Ryan Edward Brown , a net sale of 25,500 shares made by Wigzell Hans Lennart Rudolf , and a net sale of 13,757 shares made by Bilal Arif .

In summary, during the past 3 months, insiders sold 2,491 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 2,491 shares. During the past 18 months, 99,057 shares of Sarepta Therapeutics Inc (SRPT) were sold and 112,263 shares were bought by its insiders, resulting in a net purchase of 13,206 shares.

Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sarepta Therapeutics Inc Insider Transactions

No Available Data

Guriqbal S. Basi Mailing Address

Above is the net worth, insider trading, and ownership report for Guriqbal S. Basi. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Guriqbal S. Basi's mailing address is: Cambridge Ma 02142.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.